Literature DB >> 7776835

Role of cyclic AMP dependent protein kinase in cannabinoid receptor modulation of potassium "A-current" in cultured rat hippocampal neurons.

R E Hampson1, G J Evans, J Mu, S Y Zhuang, V C King, S R Childers, S A Deadwyler.   

Abstract

Cannabinoid receptor agonists have been previously shown to enhance a potassium A-current (IA) in cultured rat hippocampal neurons. This effect has been further demonstrated to be dependent on G-protein linkage to adenylyl cyclase and levels of intracellular cyclic AMP (cAMP). The present study extends this analysis to the involvement of cAMP-dependent protein kinase (PKA) in this cascade. Specific activators and inhibitors of PKA were shown to have differential effects on the voltage dependence of IA. Specific activators of PKA produced a negative shift in voltage dependence of IA, whereas PKA inhibitors produced a positive shift in IA voltage dependence, the latter similar to that effected by the cannabinoid agonist WIN 55,212-2. Although the negative shift in IA induced by PKA stimulation could be reversed by PKA inhibitors, the positive shift produced by the PKA inhibitors alone was only 50-60% of the cannabinoid-produced shift in IA voltage dependence. This partial effect of PKA inhibition was confirmed by biochemical assays in the same cultured neurons that showed a similar 50-60% decrement in in vitro protein phosphorylation produced by PKA inhibitors. Results are discussed in terms of a diffusible second messenger linkage of the cannabinoid receptor to the A-current channel via the role of protein phosphorylation in modulation of IA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7776835     DOI: 10.1016/0024-3205(95)00192-9

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  15 in total

1.  AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: implications for opioid/cannabinoid interaction studies.

Authors:  Kathryn A Seely; Lisa K Brents; Lirit N Franks; Maheswari Rajasekaran; Sarah M Zimmerman; William E Fantegrossi; Paul L Prather
Journal:  Neuropharmacology       Date:  2012-07-04       Impact factor: 5.250

Review 2.  The complications of promiscuity: endocannabinoid action and metabolism.

Authors:  S P H Alexander; D A Kendall
Journal:  Br J Pharmacol       Date:  2007-09-17       Impact factor: 8.739

3.  Short-term retrograde inhibition of GABAergic synaptic currents in rat Purkinje cells is mediated by endogenous cannabinoids.

Authors:  Marco A Diana; Carole Levenes; Ken Mackie; Alain Marty
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

Review 4.  Cannabinoid receptors and their endogenous agonist, anandamide.

Authors:  J Axelrod; C C Felder
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

5.  L-type calcium channel mediates anticonvulsant effect of cannabinoids in acute and chronic murine models of seizure.

Authors:  Nima Naderi; Leila Ahmad-Molaei; Ali Mazar-Atabaki; Abdolaziz Ronaghi; Zahra Shirazi-zand; Seyed Mehrdad Motiei-Langroudi; Somayeh Eslahkar
Journal:  Neurochem Res       Date:  2011-09-18       Impact factor: 3.996

6.  Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain.

Authors:  L J Sim; R E Hampson; S A Deadwyler; S R Childers
Journal:  J Neurosci       Date:  1996-12-15       Impact factor: 6.167

Review 7.  Marijuana, endocannabinoids, and epilepsy: potential and challenges for improved therapeutic intervention.

Authors:  Mackenzie E Hofmann; Charles J Frazier
Journal:  Exp Neurol       Date:  2011-12-09       Impact factor: 5.330

8.  The modulation of voltage-gated potassium channels by anisotonicity in trigeminal ganglion neurons.

Authors:  L Chen; C Liu; L Liu
Journal:  Neuroscience       Date:  2008-03-29       Impact factor: 3.590

Review 9.  Cannabinoids and Epilepsy.

Authors:  Evan C Rosenberg; Richard W Tsien; Benjamin J Whalley; Orrin Devinsky
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

10.  Role of the endogenous cannabinoid system as a modulator of dopamine transmission: implications for Parkinson's disease and schizophrenia.

Authors:  F Rodríguez De Fonseca; M A Gorriti; A Bilbao; L Escuredo; L M García-Segura; D Piomelli; M Navarro
Journal:  Neurotox Res       Date:  2001-01       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.